Balance Sheet
Cash Flow Statement
AcquisitionsAmortizationAmortizationAmortization of Deferred ChargesAmortization of Deferred ChargesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in IntangiblesChange in ReceivablesChange in ReceivablesDeferred TaxesDividends Paid - CommonDividends Paid - CommonExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Repurchased
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Qiagen (QGEN) Capital Expenditures (2021 - 2026)

Qiagen's Capital Expenditures history spans 11 years, with the latest figure at -$46.9 million for Q1 2026.

  • On a quarterly basis, Capital Expenditures fell 6.79% to -$46.9 million in Q1 2026 year-over-year; TTM through Mar 2026 was -$333.9 million, a 14.12% decrease, with the full-year FY2025 number at $201.0 million, up 20.26% from a year prior.
  • Capital Expenditures hit -$46.9 million in Q1 2026 for Qiagen, up from -$201.0 million in the prior quarter.
  • Over the last five years, Capital Expenditures for QGEN hit a ceiling of -$24.9 million in Q3 2022 and a floor of -$201.0 million in Q4 2025.
  • Historically, Capital Expenditures has averaged -$60.5 million across 5 years, with a median of -$40.0 million in 2025.
  • Biggest five-year swings in Capital Expenditures: soared 59.69% in 2023 and later tumbled 221.15% in 2024.
  • Tracing QGEN's Capital Expenditures over 5 years: stood at -$129.0 million in 2022, then soared by 59.69% to -$52.0 million in 2023, then tumbled by 221.15% to -$167.0 million in 2024, then decreased by 20.36% to -$201.0 million in 2025, then soared by 76.68% to -$46.9 million in 2026.
  • Business Quant data shows Capital Expenditures for QGEN at -$46.9 million in Q1 2026, -$201.0 million in Q4 2025, and -$46.0 million in Q3 2025.